Clinical Trials

 

Description of neurolOgical Involvement Observed During SARS COV2 Infection

Intervention Type: Other
Study Type: Observational
Sponsors: Centre d'Investigation Clinique et Technologique 805
Participants: 30
Authors
Eric Azabou, Robert Carlier, Marie Christine Durand
Abstract
Description of the neurological impairment: clinico-radiological and electrophysilogical correlations
* Consult with your doctor before enrolling in clinical trials.
Facilities
Hopital Raymond Poincare - Recruiting
Garches, France
Contacts
Backup
Isabelle Bossard
Primary
David Orlikowski, MD PhD
david.orlikowski@aphp.fr
0147107777
Eligibilities
Sex: All
Minimum Age: 18
Inclusion Criteria:
- PCR SARS COV2 positive or CT Scan
- Central neurological signs such as confusion, epilepsy, abnormal movement, pyramidal signs, motor or sensory deficit, involvement of cranial pairs (such as anomie or ageusia) or peripheral.
- Dysautonomic signs such as hypotension or hypertension, bradycardia or tachycardia, hypothermia, SIADH not explained by therapy or a pathology other than SARS COV 2 infection
Exclusion Criteria:
- Contraindication to performing an MRI scan
- Minor
- Pregnant woman
- No follow-up possible at 6 months

View Article From Source